Last updated: February 7, 2023
Sponsor: Canisius College
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Autism Spectrum Disorder (Asd)
Treatment
N/AClinical Study ID
NCT05542602
IRB 2021-22 #40
CDMRP-AR210161
Ages 7-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Prior clinical diagnosis of ASD
- Wechsler Abbreviated Scale of Intelligence-2nd Edition IQ score >70
- Diagnostic confirmation via the Autism Diagnostic Interview-Revised
Exclusion
Exclusion Criteria:
- Evidence of psychosis per parent report and prior psychiatric evaluation
Study Design
Total Participants: 48
Study Start date:
December 10, 2022
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
Canisius College
Buffalo, New York 14208
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.